Circulation
-
Evidence regarding the use of direct oral anticoagulants (DOACs) in the elderly, particularly bleeding risks, is unclear despite the presence of greater comorbidities, polypharmacy, and altered pharmacokinetics in this age group. ⋯ http://www.crd.york.ac.uk/PROSPERO. Unique identifier: PROSPERO CRD42014007171/.